The 3rd Annual London Biotechnology Show Accelerating the Future of Health at the 3rd London Biotechnology Show

Event Highlights

Join industry leaders, innovators, and researchers at the London Biotechnology Show to explore groundbreaking advancements in red biotechnology. Discover new opportunities, connect with key stakeholders, and elevate your presence in the global biotech landscape.

Exhibition

The London Biotechnology Show Exhibition is your gateway to the latest breakthroughs shaping the future of global healthcare and beyond. Explore an expansive showcase of next-generation medical technologies, advanced therapeutics, cutting-edge diagnostics, and transformative solutions from leading biotech companies, startups, and research institutions. Engage with interactive product demonstrations and discover pioneering advancements across healthcare, research, pharmaceuticals, and the broader biotech value chain. This is the place to witness first-hand the innovations redefining the boundaries of life sciences.

Conference

The London Biotechnology Show 2026 Conference convenes the world’s foremost thought leaders, innovators, and policymakers to address the most pressing topics in biotechnology. Featuring a robust agenda of keynote sessions and panel discussions, the conference delivers actionable insights on gene and cell therapies, digital health, precision medicine, the future of biotechnology and more. Designed for researchers, industry executives, investors, and policymakers, this flagship gathering is where transformative ideas spark real-world impact.

Networking

Forge valuable connections with top-tier biotech executives, scientists, investors, and policymakers at the London Biotechnology Show 2026. Exclusive networking sessions foster collaboration, knowledge exchange, and strategic partnerships across the entire biotechnology value chain. With a diverse international audience, this event is the nexus for building relationships that accelerate innovation and drive growth in the life sciences sector.

Global Biotechnology Awards

The Global Biotechnology Awards at the London Biotechnology Show celebrate pioneering achievements by companies across the biotech ecosystem. From therapeutic breakthroughs and precision diagnostics to industrial biotech and synthetic biology, these awards spotlight organisations making a lasting global impact through science-driven innovation.

Buyer Programme

The London Biotechnology Show’s Buyer Programme offers a tailored platform for qualified buyers to connect directly with leading suppliers and solution providers. This initiative supports the expanding biotech marketplace by facilitating high-value engagements and strategic collaborations that fuel mutual growth and innovation.

Startup Scaleup

The Startup scaleup platform pioneers emerging biotech ventures, providing startups with the stage to showcase disruptive ideas, pitch to investors, and gain critical exposure to industry leaders. This initiative celebrates the ingenuity and entrepreneurial spirit driving the next wave of breakthroughs in biotechnology and healthcare.

9 – 10 June 2026

Location: Excel London

The London Biotech Show 2026 is Europe’s leading platform for the biotechnology industry, showcasing the full spectrum of red biotech including biopharmaceuticals, therapeutics, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical trials, and biomanufacturing.

The event will bring together biotech companies, pharmaceutical leaders, medtech innovators, investors, researchers, policymakers, and solution providers from across the globe to exchange knowledge, forge partnerships, and accelerate innovation.

Through its world-class exhibition, high-level conference, and the Global Biotech Awards, the show enables attendees to explore cutting-edge technologies, secure investments, expand into new markets, and drive the next wave of breakthroughs in healthcare and life sciences.

The event offers a unique platform for key stakeholders to connect and engage across the entire red biotech value chain.

Featuring a comprehensive conference agenda, the event will host a broad spectrum of top-notch speaker keynotes & panel discussions focusing on the latest developments in the red biotechnology vertical. The conference will provide an apt platform for global thought leaders, decision-makers and industry pioneers to share deep industry insights, exchange key ideas.

The show will spotlight cutting-edge innovations across healthcare, research, and life sciences, showcasing the future of biotech on a global stage.

The exhibition at #LBS26 offers a premier platform for leading biotech players and emerging ventures to showcase cutting-edge innovations shaping healthcare, life sciences, and beyond, connecting directly with an international community of stakeholders.

More information about the event can be found here

Event Highlights

Join industry leaders, innovators, and researchers at the London Biotechnology Show to explore groundbreaking advancements in red biotechnology. Discover new opportunities, connect with key stakeholders, and elevate your presence in the global biotech landscape.

Exhibition

The London Biotechnology Show Exhibition is your gateway to the latest breakthroughs shaping the future of global healthcare and beyond. Explore an expansive showcase of next-generation medical technologies, advanced therapeutics, cutting-edge diagnostics, and transformative solutions from leading biotech companies, startups, and research institutions. Engage with interactive product demonstrations and discover pioneering advancements across healthcare, research, pharmaceuticals, and the broader biotech value chain. This is the place to witness first-hand the innovations redefining the boundaries of life sciences.

Conference

The London Biotechnology Show 2026 Conference convenes the world’s foremost thought leaders, innovators, and policymakers to address the most pressing topics in biotechnology. Featuring a robust agenda of keynote sessions and panel discussions, the conference delivers actionable insights on gene and cell therapies, digital health, precision medicine, the future of biotechnology and more. Designed for researchers, industry executives, investors, and policymakers, this flagship gathering is where transformative ideas spark real-world impact.

Networking

Forge valuable connections with top-tier biotech executives, scientists, investors, and policymakers at the London Biotechnology Show 2026. Exclusive networking sessions foster collaboration, knowledge exchange, and strategic partnerships across the entire biotechnology value chain. With a diverse international audience, this event is the nexus for building relationships that accelerate innovation and drive growth in the life sciences sector.

Global Biotechnology Awards

The Global Biotechnology Awards at the London Biotechnology Show celebrate pioneering achievements by companies across the biotech ecosystem. From therapeutic breakthroughs and precision diagnostics to industrial biotech and synthetic biology, these awards spotlight organisations making a lasting global impact through science-driven innovation.

Buyer Programme

The London Biotechnology Show’s Buyer Programme offers a tailored platform for qualified buyers to connect directly with leading suppliers and solution providers. This initiative supports the expanding biotech marketplace by facilitating high-value engagements and strategic collaborations that fuel mutual growth and innovation.

Startup Scaleup

The Startup scaleup platform pioneers emerging biotech ventures, providing startups with the stage to showcase disruptive ideas, pitch to investors, and gain critical exposure to industry leaders. This initiative celebrates the ingenuity and entrepreneurial spirit driving the next wave of breakthroughs in biotechnology and healthcare.

16th biennial Frontiers in Low Temperature Plasma Diagnostics (FLTPD) workshop 12 - 16 April 2026

VENUE

The conference will be held in Rolduc, a medieval abbey located on the edge of the town of Kerkrade in the far south-east of the Netherlands. It is today a Roman Catholic seminary with an affiliated conference centre. The abbey is a rijksmonument (Dutch national heritage site). Hotel rooms provided on-site (part of the registration).

More info here

Kerkrade, The Netherlands

The FLTPD workshop is organized by Eindhoven University of Technology. It will be held in an old abbey Rolduc in Kerkrade, in the south of The Netherlands.
It will take place from the 12th to the 16th of April 2026.

FLTPD workshop brings together scientists working on low-temperature plasmas to present their recent results, focusing on original diagnostic techniques. The workshop is limited to approximately 80 participants from academic, research and industrial institutions. The program consists of expert presentations from around 10 invited speakers, topical talks selected by the International Scientific Committee from submitted abstracts, and poster contributions. All participants will stay at the conference site and are expected to present a contribution.
This is an important and fruitful opportunity for young plasma scientists to share and discuss the latest developments in plasma diagnostics with the experts in the field.

VENUE

The conference will be held in Rolduc, a medieval abbey located on the edge of the town of Kerkrade in the far south-east of the Netherlands. It is today a Roman Catholic seminary with an affiliated conference centre. The abbey is a rijksmonument (Dutch national heritage site). Hotel rooms provided on-site (part of the registration).

More info here

Ignite Plasma at ICPIG 2025 INTERNATIONAL CONFERENCE ON PHENOMENA IN IONIZED GASES 36TH EDITION 20/07/2025

The conference proved to be an incredibly rewarding experience, with our work receiving outstanding feedback from the plasma physics community, particularly highlighting:

✨ Our Key Innovations:

✅ Novel closed-loop systems for controlling excited species and power.
✅ Advanced 4-axis programmable translational stage system enabling more precise and efficient in vivo experiments
✅ User-friendly intuitive interface designed for seamless operation

The event was a fantastic opportunity to connect with fellow researchers and learn about cutting-edge developments in plasma physics and technology, including fascinating work on advanced diagnostics such as E-FISH and TALIF techniques that are pushing the boundaries of fundamental physicochemical research on plasma.

Thank you to all the brilliant minds we connected with at ICPIG 2025 – the exchange of ideas and positive reception of our work truly energizes our mission to advance plasma technology applications.

🔗 Excited for what’s next — collaborations, innovations, and further progress.

Follow us on #IgnitePLASMA

JULY 20TH/25TH – AIX EN PROVENCE, FRANCE

As part of the Ignite Plasma representation at the International Conference on Phenomena in Ionized Gases, ICPIG 2025, Konstantinos Giotis presented our latest progress on our innovative platform development.

Konstantinos is a valuable team member of our consortium partner ECE, University of Patras and, after of more than a year’s hard work, the team is proud to showcase their achievements.

Poster ICPIG 2025

More information can be found here

The conference proved to be an incredibly rewarding experience, with our work receiving outstanding feedback from the plasma physics community, particularly highlighting:

✨ Our Key Innovations:

✅ Novel closed-loop systems for controlling excited species and power.
✅ Advanced 4-axis programmable translational stage system enabling more precise and efficient in vivo experiments
✅ User-friendly intuitive interface designed for seamless operation

The event was a fantastic opportunity to connect with fellow researchers and learn about cutting-edge developments in plasma physics and technology, including fascinating work on advanced diagnostics such as E-FISH and TALIF techniques that are pushing the boundaries of fundamental physicochemical research on plasma.

Thank you to all the brilliant minds we connected with at ICPIG 2025 – the exchange of ideas and positive reception of our work truly energizes our mission to advance plasma technology applications.

🔗 Excited for what’s next — collaborations, innovations, and further progress.

Follow us on #IgnitePLASMA

Ignite Plasma Presents Research COST ACTION PLASTHER FINAL MEETING 17/06/2025

Research Objectives

To address this challenge, the research focuses on identifying the RONS that can penetrate biological barriers and determining the physical parameters able to modulate them. The team is working to optimize factors such as gas flow rate and electric field intensity using a conventional double ring-electrodes plasma jet supplied with helium at 1 L/min and applying nanopulse high-voltage parameters of 0-10 kV, 0-30 kHz, and 10%.

Moving Forward

This presentation at the Plaster Cost Action meeting represents another step in Ignite Plasma’s research into plasma-based cancer therapies. The collaboration with Laboratory of Plasma Physics, Sorbonne University and Inserm, Centre de Recherche Saint-Antoine in Paris continues to advance our understanding in this field of medical research.

For more information about Ignite Plasma’s research initiatives and partnerships, please contact us or Follow us: #IgnitePlasma

Jun 17 – 20 2025 Barcelona, Spain

Ignite Plasma participated in the Plaster Cost Action meeting in June 2025, where our consortium partner Sorbonne University represented our research in cold atmospheric plasma therapy.

Emerick Biaffeu, a team member from Sorbonne University’s Laboratory of Plasma Physics in France, presented his team’s research on behalf of Ignite Plasma, focusing on the therapeutic potential of cold atmospheric plasma (CAP) for treating challenging cancer types.

Research Focus

The presentation outlined CAP as a promising therapeutic approach for patients suffering from cholangiocarcinoma (CCA – cancer of the biliary tract) and pancreatic ductal adenocarcinoma (PDAC) inducing selective cytotoxic effects. These effects can be mediated by different properties of CAP, e.g. reactive oxygen and nitrogen species (RONS) and electric field.

The research has shown CAP’s anti tumor efficacy through tumor growth regression in murine models carrying subcutaneous tumors. However, the team recognizes that in patient situations, epithelial tissue may influence the penetration of plasma-generated species, potentially reducing treatment efficacy.

Poster A Plaster COST Action Meeting

More information can be found here

Research Objectives

To address this challenge, the research focuses on identifying the RONS that can penetrate biological barriers and determining the physical parameters able to modulate them. The team is working to optimize factors such as gas flow rate and electric field intensity using a conventional double ring-electrodes plasma jet supplied with helium at 1 L/min and applying nanopulse high-voltage parameters of 0-10 kV, 0-30 kHz, and 10%.

Moving Forward

This presentation at the Plaster Cost Action meeting represents another step in Ignite Plasma’s research into plasma-based cancer therapies. The collaboration with Laboratory of Plasma Physics, Sorbonne University and Inserm, Centre de Recherche Saint-Antoine in Paris continues to advance our understanding in this field of medical research.

For more information about Ignite Plasma’s research initiatives and partnerships, please contact us or Follow us: #IgnitePlasma

Final Meeting COST Action PlasTHER

ORGANIZER

COST – EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY

This Action is concerned with the medical and biomedical applications of cold atmospheric plasmas. The main aim of the PlasTHER COST Actionis to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s science and healthcare world leaders in this field.

In this sense, PlasTHER COST Action aims at establishing a synergistic networkthat articulates researchers, the medical community, industry and patient associations, among others, and coordinate the European activity in this domain to foster the leadership of Europe in this emerging field.

More info here

Therapeutical Applications of Cold Plasma

Jun 17 – 20 2025 Barcelona, Spain

The Final Meeting of COST Action PlasTHER, which will also mark the final meeting of our action, will take place in Barcelona from the 17th to 20th June 2025.

The main aim of this COST Action has been to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s science and healthcare world leaders in this field.

The Final Meeting represents a crucial moment to meet each other, wrap up the main oblectives of the project and continue building up our community in order to keep addressing our common objective of improving the performance of plasma therapies for the benefit of the patients.

During the meeting, we will focus on the COST tasks of all our working groups, working together for the production of the specific final deliverables. Also, it is of great importance to present the results of the STSMs performed in the last year among PlasTHER members.

Dr. Cristina Canal

ORGANIZER

COST – EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY

This Action is concerned with the medical and biomedical applications of cold atmospheric plasmas. The main aim of the PlasTHER COST Actionis to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s science and healthcare world leaders in this field.

In this sense, PlasTHER COST Action aims at establishing a synergistic networkthat articulates researchers, the medical community, industry and patient associations, among others, and coordinate the European activity in this domain to foster the leadership of Europe in this emerging field.

More info here

4th Training School “Bridging Science and Innovation: Translating Plasma Medicine into Clinic and to the Market” In Strbske Pleso, Slovakia from January 28th to 31st, 2025.

“Bridging Science and Innovation: Translating Plasma Medicine into Clinic and to the Market”

This training school aims to equip PhD students and early career researchers with the skills and knowledge needed to successfully navigate the journey from groundbreaking research in plasma medicine to real-world market applications. Through a series of expert-led talks and interactive sessions, participants will gain valuable insights into the multifaceted process of technology transfer and commercialization.

The program features first-hand experiences from startup founders in the plasma medicine field, highlighting both challenges and successes. Sessions on clinical microbiology and clinical aspects will provide a deeper understanding of the medical applications and potential of plasma technologies. Key topics such as intellectual property protection, patenting strategies, and DIN standardization will be covered to help participants understand the regulatory landscape and how to safeguard innovations.

Finally, a session on effective science communication will teach participants how to present their research with clarity and impact, ensuring their findings resonate with diverse audiences, from investors to clinicians.

The training school is specially oriented to young researchers, PhD students and all other colleagues interested in approaching this topic.

One of our team members, George Vafakos, had the opportunity to attend the 4th Training School “Bridging Science and Innovation: Translating Plasma Medicine into Clinic and to the Market” of the PlasTHER Cost Action.

The participants had the opportunity to present their work and elaborate on the projects they are involved in.

This training school prepares early career researchers to transition plasma medicine research into market applications through expert-led sessions on technology transfer, commercialization, and regulatory aspects. It covers key topics like intellectual property, standardization, clinical applications, and science communication, with insights from startup founders and industry experts.

More information can be found here

“Bridging Science and Innovation: Translating Plasma Medicine into Clinic and to the Market”

This training school aims to equip PhD students and early career researchers with the skills and knowledge needed to successfully navigate the journey from groundbreaking research in plasma medicine to real-world market applications. Through a series of expert-led talks and interactive sessions, participants will gain valuable insights into the multifaceted process of technology transfer and commercialization.

The program features first-hand experiences from startup founders in the plasma medicine field, highlighting both challenges and successes. Sessions on clinical microbiology and clinical aspects will provide a deeper understanding of the medical applications and potential of plasma technologies. Key topics such as intellectual property protection, patenting strategies, and DIN standardization will be covered to help participants understand the regulatory landscape and how to safeguard innovations.

Finally, a session on effective science communication will teach participants how to present their research with clarity and impact, ensuring their findings resonate with diverse audiences, from investors to clinicians.

The training school is specially oriented to young researchers, PhD students and all other colleagues interested in approaching this topic.

This week in Mathematical Oncology Featured Artwork 30/01/2025 BY Artist: Vasileios Vavourakis (in Silico Modeling Group, University of Cyprus, Cyprus)

FEATURED ARTWORK…

In this direction, we developed a data-driven computer modeling tool that can simulate needle insertion and prostate tissue deformation during HDR-BRT. Our tool can integrate magnetic resonance imaging and ultrasound data from prostate cancer patients, and has been tested to recapitulate catheter insertion during HDR-BRT. The simulation tool ability to realistically capture this process and to accurately predict the prostate deformation is evaluated against comprehensive clinical images from cancer patients in Cyprus. This contribution demonstrates our first milestone towards a digital platform for pre-operative planning and intra-operative guidance optimization of HDR-BRT.

Our efforts are now intensified in the research project PROTECT (https://protect-prostate.eu) where we will refine the modelling and image computing algorithms and tools towards high-fidelity personalized brachytherapy in prostate cancer management.

Check out the artwork and write-up here in “This Week in MathOnco”

Based on the paper: Personalised in silico biomechanical modelling towards the optimisation of high dose-rate brachytherapy planning and treatment against prostate cancer published in Frontiers in Physiology

Caption: We explored recently a novel computational approach that can enhance the accuracy of high dose-rate brachytherapy (HDR-BRT), a therapeutic modality against prostate cancer. HDR-BRT involves temporary insertion of radioactive source-carrying catheters into the prostate. However, catheter insertion is a task that is highly dependent on the experience of the treating physician which in turn defines the accuracy and therapeutic outcome of brachytherapy.

FEATURED ARTWORK…

In this direction, we developed a data-driven computer modeling tool that can simulate needle insertion and prostate tissue deformation during HDR-BRT. Our tool can integrate magnetic resonance imaging and ultrasound data from prostate cancer patients, and has been tested to recapitulate catheter insertion during HDR-BRT. The simulation tool ability to realistically capture this process and to accurately predict the prostate deformation is evaluated against comprehensive clinical images from cancer patients in Cyprus. This contribution demonstrates our first milestone towards a digital platform for pre-operative planning and intra-operative guidance optimization of HDR-BRT.

Our efforts are now intensified in the research project PROTECT (https://protect-prostate.eu) where we will refine the modelling and image computing algorithms and tools towards high-fidelity personalized brachytherapy in prostate cancer management.

Check out the artwork and write-up here in “This Week in MathOnco”

EIC Summit 2025 EIC BENEFICIARIES DAY

EIC Summit 2025

Wednesday 2 April 2025 – Thursday 3 April 2025

Venue

The EIC Summit 25 will take place in the historical Tour & Taxis site on the Brussels Canal.

Stay updated by visiting the official event page

Welcome to the 2025 edition of the EIC Summit, Europe’s prime event where deeptech meets policy.

Join us for two dynamic days featuring exclusive workshops, pitching sessions, unparalleled networking opportunities and groundbreaking projects. Register now Don’t miss the opportunity to connect with key players shaping Europe’s deeptech landscape. Explore groundbreaking EIC projects and discover how the EIC can support your innovations on their path to market.

Agenda Wednesday 2 April 2025 – EIC beneficiaries day Day 1, 2 April 2025, is an invitation only day, exclusively for and will be fully dedicated to EIC beneficiaries with workshops covering diverse issues, such as investments, IP, or scaling up your company.

Beneficiaries day programme Thursday 3 April 2025 – Flagship event Day 2, 3 April 2025, is our flagship event, open to all interested stakeholders – immerse yourself in inspiring plenary speeches, visionary insights, and the thrilling celebration of the EIC Prizes awards! Flagship event programme Speakers Hear from the pioneers of innovation in Europe, visionary scientists, entrepreneurs, investor and policy makers to get inspired. Discover the speakers! Networking Benefit from great networking oportunties. Upon registration, download the dedicated EIC Summit networking app. Be ready to schedule your meetings and network through the whole event! Project exhibition The Summit will showcase an exhibition of projects funded by the European Innovation Council across various schemes. More details on the exhibitors will be shared soon! Satellite events Two satellite events will take place during the EIC Summit 2025: the EIC Community Training – Artificial intelligence (AI) tools for innovators on 1 April in Brussels, and the Pathfinder Challenges Info Day on 4 April at Borschette. Discover them and register now! EIC Prizes Stay tuned and discover the winners of the European Innovation Council Prizes! On 2 April, we will award the winners of the European Innovation Procurement Awards, and on 3 April, the European Prize for Women Innovators. Get to know more about the EIC Prizes. Venue The EIC Summit 25 will take place in the historical Tour & Taxis site on the Brussels Canal.

Have a look to the venue details! EIC Summit 2024 Curious about the previous edition? Go to the EIC Summit 2024 edition for recording, photos and more.

EIC Summit 2025

Wednesday 2 April 2025 – Thursday 3 April 2025

Venue

The EIC Summit 25 will take place in the historical Tour & Taxis site on the Brussels Canal.

Stay updated by visiting the official event page

MEDTECH SUMMIT

Spotlight on the opportunities and challenges of the healthcare industry,

now for the 7th time!

BUDAPEST 2025

In 2025, one of the most important regional event for medtech researchers, startups, QA (Quality Assurance) & RA (Regulatory Affairs) professionals, manufactures and investors and will take place in a new two-day format. The event is unmissable due to its highly professional content on all segments of the medical device industry and the unique international business networking opportunities.

Technological innovations, regulatory trends, development resources, regulatory expectations, and best manufacturing practices will continue to be in focus – all in one place at the MedTech Summit Budapest Conference!

The event supports business development opportunities with targeted B2B meetings, as this event has become one of the most important meeting points for healthcare industry participants. The record-breaking number of participants each year attests that this event is not to be missed. Leaders from healthcare, medical technology, pharmaceutical, and cosmetic companies, as well as ministries, authorities, research institutions, universities, test labs, consultants, and notified bodies, will all be present from all around the world.

more info

Spotlight on the opportunities and challenges of the healthcare industry,

now for the 7th time!

European Health Data & Innovation Summit 30/01/2025

The event includes the stakeholder forum of TEHDAS2, a joint action preparing

the ground for the harmonised implementation

of the secondary use of health data in the EHDS.

CIC WARSAW ON-SITE | ONLINE

The European Health Data and Innovation Summit is an event on the future of healthcare, focusing on the use of health data and innovative technologies.

The meeting will bring together experts from the public sector, the private sector and the European institutions to present the latest solutions to support the development of personalised medicine and the improvement of health services. The European Health Data Space (EHDS) and innovations in healthcare will be the main topics of debate.

more info

The event includes the stakeholder forum of TEHDAS2, a joint action preparing

the ground for the harmonised implementation

of the secondary use of health data in the EHDS.